IJSR - International Journal of Scientific Research

Ashwani Kumar; Dr. B. Shrivastava; Dr. Sonu Sharma

Volume : VIII, Issue : VIII, August - 2019

A Correlative study of Anxiety and Depression in Cervical Cancer Women: A triple trouble

Ashwani Kumar, Dr. B. Shrivastava, Dr. Sonu Sharma

Abstract :

Background: The Patient Health Questionnaire (PHQ–9) and Generalized Anxiety Disorder (GAD–7) is a screening tool for measuring anxiety and depression in Cervical Cancer women. The aim of this study was to assess the burden of anxiety and depression in cervical cancer patients with reference to age and socioeconomic conditions. Methods: A sample of 200 patients with cervical cancer were examined in this study for one year from June 2016 to June 2017 at Mahavir Cancer Sansthan, Patna, India.Patient’s data were collected using threesets of questionnaires in which one questionnaire consist of demographic and socioeconomic characteristics of the patients. The second questionnaire was Generalized Anxiety Disorder (GAD–7) and the third one was Public health questionnaire (PHQ–9) which measures the depression among the cervical women.This questionnaire is commonly said to be HADS Questionnaire (Hospital Anxiety and Depression). Result:A total of 200 cervical women were included in this study from June 2016 to June 2017. Patients were diagnosed with cancer and completed the screening tools. The mean and SD of anxiety was 11±4.10 and the mean and SD of depressions was found to be 12.49±4.91. The percentage prevalence of depression was found to be 6% (screen negative), 22% (screen at risk) and 72% (screen positive).The prevalence of anxiety was found to be 13% (screen negative), 26% (screen at risk) and 61% (screen positive). Conclusion: The study shows a screening of both depression and anxiety symptoms is important for all cervical cancer patients. The low socioeconomic condition, illiteracy, and lack of knowledge among rural patients are the most prominent causes ofthe high level of depression and anxiety. The study suggests that the assessment of anxiety and depression is as important as chemotherapy to improve the quality of life of cervix cancer patients.